Abstract:Background. Obesity is a global epidemic in the industrialized and developing world, and many children suffer from obesity-related complications. Gut microbiota dysbiosis might have significant effect on the development of obesity. The microbiota continues to develop through childhood and thus childhood may be the prime time for microbiota interventions to realize health promotion or disease prevention. Therefore, it is crucial to understand the structure and function of pediatric gut microbiota. Methods. According to the inclusion criteria and exclusion criteria, twenty-three normal weight and twenty-eight obese children were recruited from Nanjing, China. Genomic DNA was extracted from fecal samples. The V4 region of the bacterial 16S rDNA was amplified by PCR, and sequencing was applied to analyze the gut microbiota diversity and composition using the Illumina HiSeq 2500 platform. Results. The number of operational taxonomic units (OTUs) showed a decrease in the diversity of gut microbiota with increasing body weight. The alpha diversity indices showed that the normal weight group had higher abundance and observed species than the obese group (Chao1: P < 0.001; observed species: P < 0.001; PD whole tree: P < 0.001; Shannon index: P = 0.008). Principal coordinate analysis (PCoA) and Nonmetric multidimensional scaling (NMDS) revealed significant differences in gut microbial community structure between the normal weight group and the obese group. The liner discriminant analysis (LDA) effect size (LEfSe) analysis showed that fifty-five species of bacteria were abundant in the fecal samples of the normal weight group and forty-five species of bacteria were abundant in the obese group. In regard to phyla, the gut microbiota in the obese group had lower proportions of Bacteroidetes (51.35%) compared to the normal weight group (55.48%) (P = 0.030). There was no statistical difference in Firmicutes between the two groups (P = 0.436), and the Firmicutes/Bacteroidetes between the two groups had no statistical difference (P = 0.983). At the genus level, Faecalibacterium, Phascolarctobacterium, Lachnospira, Megamonas, and Haemophilus were significantly more abundant in the obese group than in the normal weight group (P = 0.048, P = 0.018, P < 0.001, P = 0.040, and P = 0.003, respectively). The fecal microbiota of children in the obese group had lower proportions of Oscillospira and Dialister compared to the normal weight group (P = 0.002 and P = 0.002, respectively). Conclusions. Our results showed a decrease in gut microbiota abundance and diversity as the BMI increased. Variations in the bacterial community structure were associated with obesity. Gut microbiota dysbiosis might play a crucial part in the development of obesity in Chinese children.

Role of oral and gut microbiota in childhood obesity

Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years

The critical role of gut microbiota in obesity

Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents

Link between childhood obesity and gut microbiota

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Correlation of Gut Microbiota with Children Obesity and Weight Loss

Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

An overview of traditional Chinese medicine affecting gut microbiota in obesity

Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders

The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms

Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases

Unraveling the roles of Gut microbiota in predisposition to and progression of obesity and related metabolic disorders

Gut microbiota profiling in obese children from Southeastern China

Functional Dynamics of Gut Microbiota in Obesity and Metabolic Diseases

Gut microbiota and obesity: implications for fecal microbiota transplantation therapy

The role of the gut microbiota on the metabolic status of obese children

Gut microbiota and therapy for obesity and type 2 diabetes

Gut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity